Versant Ventures VI GP, L.P. sold $10.1M of LENZ Therapeutics (LENZ)

Executed Jun 18 2025, disclosed Jun 20 2025, 2 days later.

Value, as filed

$10.1M

334,801 sh across 3 lots

Executed

Jun 18 2025

the trade date, as filed

Disclosed

Jun 20 2025

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

VP Versant Ventures VI GP, L.P. 10% owner profile →

Versant Ventures VI GP, L.P. (10% owner) filed 1 Form 4 report as a reporting entity in the past 24 months (0 purchases, 1 sale), most often in LENZ. The largest single filing was $10.1M of LENZ (334,801 sh across 3 lots, as filed), executed Jun 18 2025.

The name

LENZ LENZ LENZ · 11 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→